New botrydial sesquiterpenoids from Hymenoscyphus epiphyllus

Area of Science:

• Mycology
• Natural Products Chemistry
• Chemical Biology

Background:

• The ascomycete fungus Hymenoscyphus epiphyllus is a source of bioactive secondary metabolites.
• Botrydial derivatives and cytochalasins are classes of fungal compounds with diverse biological activities.

Purpose of the Study:

• To isolate and characterize new botrydial derivatives from Hymenoscyphus epiphyllus.
• To evaluate the biological activities of the isolated compounds, particularly hymendial.

Main Methods:

• Chemical isolation techniques including chromatography were employed to separate compounds from the fungal culture fluid.
• Structural elucidation of the new compounds was performed using spectroscopic methods.
• Biological assays were conducted to assess antimicrobial, cytotoxic, and mutagenic activities.

Main Results:

• Five botrydial derivatives were isolated: hymendial (1), 7 alpha-hydroxydihydrobotrydial (2), dihydrobotrydial (3), 7 alpha-hydroxy-10-O-methyldihydrobotrydial (4), and 7 alpha-acetoxy-15 alpha-methoxy-10-O-methyl-dihydrobotrydial (5).
• Cytochalasin H (6a), 18-deoxycytochalasin H (6b), and (+)-mellein (7) were also identified.
• Hymendial (1) demonstrated antimicrobial and cytotoxic effects and was found to be mutagenic in the Ames Salmonella assay.

Conclusions:

• Hymenoscyphus epiphyllus produces a range of novel and known secondary metabolites, including several botrydial derivatives.
• Hymendial is a newly identified compound with significant biological activities, including antimicrobial, cytotoxic, and mutagenic potential.
• Further investigation into hymendial and other isolated compounds may yield new therapeutic leads.